Follow The Filings

TTRX Turn Therapeutics

Turn Therapeutics earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by TTRX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TTRX insider trades
  • $308K bought by 3 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Zuraiz Chaudhary See Remarks
    Buy
    $8,750 2,500 shares at $3.50 +25% to stake
    Traded Dec 12, 2025 Filed Dec 12, 2025
    ↗
  2. Arthur F Golden Director
    Buy
    $34K 9,868 shares at $3.44 +20% to stake
    Traded Nov 24, 2025 Filed Nov 25, 2025
    ↗
  3. Arthur F Golden Director
    Buy
    $59K 20,532 shares at $2.87 +68% to stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
    ↗
  4. Zuraiz Chaudhary See Remarks
    Buy
    $7,075 2,450 shares at $2.89 +33% to stake
    Traded Nov 20–21 Filed Nov 21, 2025
    ↗
  5. Zuraiz Chaudhary See Remarks
    Buy
    $9,050 2,500 shares at $3.62 +50% to stake
    Traded Nov 17, 2025 Filed Nov 17, 2025
    ↗
  6. Abraham Chesed Insider
    Buy
    $66K 14,286 shares at $4.60 +1% to stake
    Traded Oct 23, 2025 Filed Oct 29, 2025
    ↗
  7. Zuraiz Chaudhary See Remarks
    Buy
    $25K 5,050 shares at $4.95 New stake
    Traded Oct 23, 2025 Filed Oct 23, 2025
    ↗
  8. Arthur F Golden Director
    Buy
    $100K 20,202 shares at $4.95 +202% to stake
    Traded Oct 23, 2025 Filed Oct 23, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 6 gifts and 1 stock grant.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
DEF 14A PROXY STATEMENT Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 3.02 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-K ANNUAL REPORT Filing Doc
8-K 1.01,2.03,3.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.